Kunkel Lori Anne bought ORIC
December 4, 2025 · Form 4 insider transaction
Kunkel Lori Anne bought 5,534 shares of ORIC Pharmaceuticals, Inc. at $3.75 per share, a transaction worth $20.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,534
Price
$3.75
Total value
$20.8K
InsiderKunkel Lori Anne
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 4, 2025
Filing dateDecember 5, 2025
Shares owned after74,200
OwnershipDirect
10b5-1 planNo
AmendedNo